AngioDynamics shares are trading higher after Oppenheimer upgraded the stock from Perform to Outperform and announced a $12 price target.
Portfolio Pulse from Benzinga Newsdesk
AngioDynamics' stock price increased following an upgrade from Oppenheimer, moving from Perform to Outperform with a new price target of $12.
April 05, 2024 | 5:53 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
AngioDynamics' stock price is likely to experience a short-term increase following the upgrade by Oppenheimer to Outperform and a new price target of $12.
Stock upgrades by reputable financial institutions like Oppenheimer typically lead to increased investor confidence and a subsequent rise in stock price. The setting of a new price target at $12, higher than its current trading price, suggests a positive outlook on the company's future performance, likely leading to short-term price appreciation.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100